These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 2806106)
1. [Lowering of the plasma lipid concentration with lovastatin. A clinical study in patients with primary hypercholesterolemia]. Grüneberger S; Dreyer M; Kangah R; Reinicke A; Staisch C; Steinhagen-Thiessen E; Müller P; Simon B; Dammann HG Dtsch Med Wochenschr; 1989 Nov; 114(45):1734-9. PubMed ID: 2806106 [TBL] [Abstract][Full Text] [Related]
2. [Lovastatin efficacy and tolerance in primary hypercholesterolemia. The German Lovastatin Study Group]. Thiery J; Basten A; Sommerburg C; Seidel D Dtsch Med Wochenschr; 1991 Jun; 116(23):887-94. PubMed ID: 2040207 [TBL] [Abstract][Full Text] [Related]
3. [Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study]. Forti N; Ramires JA Arq Bras Cardiol; 1991 Sep; 57(3):253-61. PubMed ID: 1824203 [TBL] [Abstract][Full Text] [Related]
4. [Clinical trial of lovastatin versus gemfibrozil in the treatment of primary hypercholesterolemia]. Catalán M; López de Ocáriz A; Alvarez MP; Ariño M; Azanza JR; Honorato J Rev Med Univ Navarra; 1992; 37(3):127-33. PubMed ID: 1480917 [TBL] [Abstract][Full Text] [Related]
5. Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial. Illingworth DR; Stein EA; Mitchel YB; Dujovne CA; Frost PH; Knopp RH; Tun P; Zupkis RV; Greguski RA Arch Intern Med; 1994 Jul; 154(14):1586-95. PubMed ID: 8031206 [TBL] [Abstract][Full Text] [Related]
6. [The comparative treatment with lovastatin and bezafibrate of primary hypercholesterolemia. A randomized and double-blind trial]. Sánchez Domínguez J; Rodríguez Padial L; Navarro A; Barcina C; Fernández E; Rivera G; Cuesta L; Lázaro-Carrasco E Rev Esp Cardiol; 1991 Apr; 44(4):251-7. PubMed ID: 2068368 [TBL] [Abstract][Full Text] [Related]
7. [Simvastatin (MK-733), a new HMG-CoA reductase inhibitor, in the treatment of hypercholesterolemia in elderly patients with atherosclerosis]. Giannini SD; de Góes JM; Dereviack BE; Machado C; Forti N; Diament J Arq Bras Cardiol; 1990 Jun; 54(6):407-14. PubMed ID: 2288531 [TBL] [Abstract][Full Text] [Related]
8. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia. Saku K; Sasaki J; Arakawa K Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571 [TBL] [Abstract][Full Text] [Related]
9. Effect of lovastatin on serum lipids in patients with nonfamilial primary hypercholesterolemia. Itskovitz HD; Flamenbaum W; De Gaetano C; Pritchard KA; Stemerman MB Clin Ther; 1989; 11(6):862-72. PubMed ID: 2611825 [TBL] [Abstract][Full Text] [Related]
10. Low plasma lipid levels and increased cholesterol synthesis after partial ileal bypass plus lovastatin in hypercholesterolemic rabbits. Tijerina O; Dombrovskis S; Esper E; Matts JP; Campos CT; Buchwald H Surgery; 1988 Oct; 104(4):796-805. PubMed ID: 3175875 [TBL] [Abstract][Full Text] [Related]
11. [Comparison between lovastatin and gemfibrozil in treatment of primary hyperlipidemias]. Bertolami MC; Martinez TL; Faludi AA; Pinto LE; Melo RS; Bismarck ZF; Batlouni M Arq Bras Cardiol; 1991 May; 56(5):407-12. PubMed ID: 1823741 [TBL] [Abstract][Full Text] [Related]
12. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia]. Lechleitner M; Sailer S; Irsigler H; Klein W; Patsch JR Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemia. Lukacsko P; Walters EJ; Cullen EI; Niecestro R; Friedhoff LT Curr Med Res Opin; 2004 Jan; 20(1):13-8. PubMed ID: 14741066 [TBL] [Abstract][Full Text] [Related]
14. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study. Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916 [TBL] [Abstract][Full Text] [Related]
15. [Effect of lovastatin on serum lipids and lipoproteins. Hungarian multicenter, open-label study]. Romics L; Karádi I; Csanády M; Gógl A; Jánosi A; Ofner P; Tarján J; Varga L; Wórum F; Zeltner G Orv Hetil; 1994 Oct; 135(40):2187-91. PubMed ID: 7970631 [TBL] [Abstract][Full Text] [Related]
16. Eggplant (Solanum melongena) extract does not alter serum lipid levels. Praça JM; Thomaz A; Caramelli B Arq Bras Cardiol; 2004 Mar; 82(3):269-76. PubMed ID: 15073652 [TBL] [Abstract][Full Text] [Related]
17. Comparative effects of two HMG-CoA reductase inhibitors (lovastatin and pravastatin) on serum lipids and lipoproteins. Richter WO; Jacob BG; Schwandt P Int J Tissue React; 1991; 13(2):107-10. PubMed ID: 1955291 [TBL] [Abstract][Full Text] [Related]
18. Lovastatin in the treatment of hypercholesterolemia in nephrotic syndrome due to diabetic nephropathy stage IV-V. Biesenbach G; Zazgornik J Clin Nephrol; 1992 Jun; 37(6):274-9. PubMed ID: 1638777 [TBL] [Abstract][Full Text] [Related]
19. Effects of lovastatin (20-80 mg daily) on lipoprotein fractions in patients with severe primary hypercholesterolemia. März W; Grützmacher P; Paul D; Siekmeier R; Schoeppe W; Gross W Int J Clin Pharmacol Ther; 1994 Feb; 32(2):92-7. PubMed ID: 8004365 [TBL] [Abstract][Full Text] [Related]
20. [Lovastatin in the treatment of hypercholesterolemia in non-insulin-dependent diabetes mellitus patients]. Zanella MT; Plavinik F; Zampieri M; Peres RB; Ribeiro AB Arq Bras Cardiol; 1993 Jul; 61(1):27-31. PubMed ID: 8285861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]